Production of Two Distinct and Independent Hepatic Immunoregulatory Molecules by the Perfused Rat Liver
- 1 September 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 5 (5) , 735-743
- https://doi.org/10.1002/hep.1840050506
Abstract
By manipulating dietary sugar intake and perfusate glucose concentration, we have identified two independent hepatic immunoregulatory molecules produced by the perfused rat liver. The first is released by injured hepatocytes, appears in perfusates together with hepatocellular glutamic pyruvic transaminase, is quantitatively inhibited by exogenous L–arginine and coelutes with arginase on high–pressure liquid chromatography. Based on these findings, we conclude that this activity is due to the release of cytoplasmic arginase from injured hepatocytes. Since supplementation studies reveal that lymphocyte proliferation is exquisitely arginine–dependent, it is conceivable that arginase released by injured hepatocytes might influence lymphocyte functionin vivoby local arginine depletion. The second immunoregulatory molecule is released by noninjured hepatocytes following induction by sugar, particularly glucose, bothin vivoorin vitro. This inducible activity is arginase–independent, triglyceride–rich and floats at a density less than 1.006 gm per ml upon ultracentrifugation. Based on these characteristics, we tentatively ascribe this activity to hepatic very low density lipoprotein, the serum counterpart of which is known to express many immunoregulatory properties. These results directly illustrate for the first time the pathophysiological conditions required for the secretion and release of these distinct and independent hepatic immunoregulatory molecules, and they suggest possible routes by which they may influence immunological homeostasis and immunologically mediated liver disease.This publication has 18 references indexed in Scilit:
- Suppression of Lymphocyte Activation by A Protein Released From Isolated Perfused Rat LiverHepatology, 1982
- Modulation of peripheral blood mononuclear cell cyclic adenosine monophosphate levels by human very low density lipoproteinCellular Immunology, 1981
- Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.Journal of Clinical Investigation, 1981
- Modulation of the in vivo immune response by human plasma very low-density lipoproteinsCellular Immunology, 1980
- Purification and properties of arginase from human liver and erythrocytesBiochemical Journal, 1978
- MAINTENANCE OF THE FUNCTIONAL STATE OF ISOLATED RAT LIVER BY HYPOTHERMIC PERFUSION WITH AN ERYTHROCYTE-FREE MEDIUMTransplantation, 1977
- EFFECT OF POLYUNSATURATED FATTY ACIDS ON SKIN ALLOGRAFT SURVIVAL AND PRIMARY AND SECONDARY CYTOTOXIC RESPONSE IN MICETransplantation, 1976
- A lymphocyte-inhibiting factor isolated from normal human liverNature, 1974
- Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich dietsJournal of Clinical Investigation, 1970
- Glutamate-Pyruvate TransaminasePublished by Elsevier ,1965